A Japanese case of ovarian mucinous adenocarcinoma with germline double variants of MSH2 and BRCA2
- PMID: 37420004
- DOI: 10.1038/s10038-023-01178-6
A Japanese case of ovarian mucinous adenocarcinoma with germline double variants of MSH2 and BRCA2
Abstract
Germline double heterozygosity (GDH) is rarely reported in cases of inherited cancer syndromes, and GDH of a mismatch repair gene and BRCA has never been reported in Japan. Nonetheless, the current report demonstrates a case of ovarian mucinous adenocarcinoma with initiated Lynch syndrome (LS)-related surveillance because of a known germline MSH2 variant. Six and a half years after oophorectomy, multiple tumors developed in the patient's lungs, bones, and lymph nodes, and histology results confirmed mucinous adenocarcinoma. Systemic chemotherapy including an anti-PD-L1 antibody was effective for >1 year, but brain metastases developed. Pathology of the brain tumors showed mucinous adenocarcinoma without expression of MSH2 and MSH6, while multi-gene panel testing demonstrated not only high microsatellite instability and a high tumor mutation burden, but also germline BRCA2 variants. Further, germline testing in relatives confirmed both variants were from the paternal line, from which many LS-related cancers develop, but not BRCA-related cancer.
© 2023. The Author(s), under exclusive licence to The Japan Society of Human Genetics.
Similar articles
-
The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).Breast Cancer Res Treat. 2020 Apr;180(2):511-514. doi: 10.1007/s10549-020-05569-7. Epub 2020 Feb 10. Breast Cancer Res Treat. 2020. PMID: 32040686
-
The Importance of Distinguishing Sporadic Cancers from Those Related to Cancer Predisposing Germline Mutations.Oncologist. 2018 Nov;23(11):1266-1268. doi: 10.1634/theoncologist.2017-0681. Epub 2018 Jun 4. Oncologist. 2018. PMID: 29866945 Free PMC article.
-
Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.Ann Hum Genet. 2022 Nov;86(6):328-352. doi: 10.1111/ahg.12482. Epub 2022 Sep 8. Ann Hum Genet. 2022. PMID: 36073783
-
Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer.Adv Anat Pathol. 2017 Nov;24(6):372-378. doi: 10.1097/PAP.0000000000000169. Adv Anat Pathol. 2017. PMID: 28820751 Free PMC article. Review.
-
Complete Response to Immune Checkpoint Inhibition in a Platinum Resistant Primary Ovarian Cancer Patient With Lynch Syndrome: A Case Report and Review of the Literature.Anticancer Res. 2023 Apr;43(4):1655-1662. doi: 10.21873/anticanres.16317. Anticancer Res. 2023. PMID: 36974818 Review.
Cited by
-
Case Report: Clinical impact of BRCA1 and BRIP1 vs. BRCA1 and BRCA2 germline double heterozygosity in ovarian cancer: a comparative case study.Front Oncol. 2025 Jul 24;15:1614373. doi: 10.3389/fonc.2025.1614373. eCollection 2025. Front Oncol. 2025. PMID: 40777133 Free PMC article.
-
Phenotypes of carriers of two mutated alleles in major cancer susceptibility genes.Breast Cancer Res Treat. 2024 Dec;208(3):589-595. doi: 10.1007/s10549-024-07454-z. Epub 2024 Aug 5. Breast Cancer Res Treat. 2024. PMID: 39102164 Free PMC article.
-
De novo familial adenomatous polyposis with germline double heterozygosity of APC/BRCA2: a case report and literature review.Hered Cancer Clin Pract. 2025 Feb 21;23(1):6. doi: 10.1186/s13053-025-00306-x. Hered Cancer Clin Pract. 2025. PMID: 39985003 Free PMC article.
References
-
- Japanese organization of Hereditary Breast and Ovarian Cancer (JOHBOC). Guidelines for Diagnosis and Treatment of Hereditary Breast and Ovarian Cancer. 2021, https://johboc.jp/guidebook_2021/ (in Japanese).
LinkOut - more resources
Research Materials
Miscellaneous